Clopidogrel vs Spironolactone: side-by-side comparison
Clopidogrel (P2Y12 receptor antagonist (antiplatelet)) and Spironolactone (Potassium-sparing diuretic / aldosterone antagonist) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Clopidogrel | Spironolactone |
|---|---|---|
| Therapeutic class | P2Y12 receptor antagonist (antiplatelet) | Potassium-sparing diuretic / aldosterone antagonist |
| CAS | 113665-84-2 | 52-01-7 |
| ATC | B01AC04 | C03DA01 |
| Molecular weight | 321.82 g/mol | 416.57 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Clopidogrel and Spironolactone share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Clopidogrel acts by a different mechanism than Spironolactone, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Clopidogrel: Clopidogrel itself is inactive; the active metabolite, formed in the liver by CYP2C19 and other cytochromes, irreversibly binds the P2Y12 ADP receptor on platelets. Spironolactone: Spironolactone competitively blocks the mineralocorticoid (aldosterone) receptor in the distal tubule of the kidney, reducing sodium reabsorption and potassium excretion.
Indications compared
Clopidogrel: Clopidogrel is approved in adults for the prevention of atherothrombotic events after recent acute coronary syndrome, recent ischaemic stroke or established peripheral arterial disease, and in patients with atrial fibril… Spironolactone: Spironolactone is approved for heart failure with reduced ejection fraction, primary hyperaldosteronism, resistant hypertension, oedema in cirrhosis or nephrotic syndrome, and certain potassium-loss states.
Safety profile
Clopidogrel: The main adverse effect is bleeding, ranging from minor bruising to severe gastrointestinal or intracranial haemorrhage. Spironolactone: Common adverse effects include hyperkalaemia (especially with renal impairment or ACE inhibitors), gynaecomastia in men, menstrual irregularities in women, and dizziness from blood pressure effects.
Frequently asked questions
Is Clopidogrel better than Spironolactone? ▾
Clopidogrel and Spironolactone are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Clopidogrel and Spironolactone be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Clopidogrel
Products with Spironolactone
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.